Skip to main content

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

  • Canaccord Genuity 43rd Annual Growth Conference: On Wednesday, August 9th, Ben Berry, Chief Financial Officer, will be meeting with investors at the conference which is scheduled to take place in Boston, MA.
  • Baird 2023 Global Healthcare Conference: On Tuesday, September 12th, Ben Berry, Chief Financial Officer, and Brady Shirley, Chief Operating Officer, will be meeting with investors at the conference, which is scheduled to take place in New York, NY.


Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit


Derek Leckow
Vice President, Investor Relations
Enovis Corporation


Source: Enovis Corporation

Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.